Procept BioRobotics Corp [PRCT] stock prices are up 2.85% to $35.0 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PRCT shares have gain 18.52% over the last week, with a monthly amount glided 9.65%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on December 08, 2025, when BofA Securities downgraded its rating to a Neutral but kept the price target unchanged to $38 for it. Previously, Oppenheimer upgraded its rating to Outperform on September 02, 2025, and kept the price target unchanged to $60. On July 09, 2025, Stephens initiated with an Overweight rating and assigned a price target of $70 on the stock. Oppenheimer started tracking the stock assigning a Perform rating. Morgan Stanley initiated its recommendation with an Overweight and recommended $105 as its price target on December 02, 2024. Jefferies started tracking with a Hold rating for this stock on November 14, 2024, and assigned it a price target of $95. In a note dated August 11, 2023, Piper Sandler initiated an Overweight rating and provided a target price of $42 on this stock.
The stock price of Procept BioRobotics Corp [PRCT] has been fluctuating between $27.80 and $97.49 over the past year. Currently, Wall Street analysts expect the stock to reach $52.83 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $35.0 at the most recent close of the market. An investor can expect a potential return of 50.94% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
The Procept BioRobotics Corp [NASDAQ:PRCT] reported sales of 299.91M for trailing twelve months, representing a surge of 42.76%. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -0.31%, Pretax Profit Margin comes in at -0.28%, and Net Profit Margin reading is -0.28%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.22 and Total Capital is -0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.94 points at the first support level, and at 32.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 35.93, and for the 2nd resistance point, it is at 36.85.
Ratios To Look Out For
It’s worth pointing out that Procept BioRobotics Corp [NASDAQ:PRCT]’s Current Ratio is 8.43. Also, the Quick Ratio is 7.19, while the Cash Ratio stands at 5.46. Considering the valuation of this stock, the price to sales ratio is 6.52, the price to book ratio is 5.14.
Transactions by insiders
Recent insider trading involved MOLL FREDERIC H, Director, that happened on Aug 13 ’25 when 20000.0 shares were purchased. Director, Desai Antal Rohit completed a deal on Jun 10 ’25 to sell 25000.0 shares. Meanwhile, Director Desai Antal Rohit sold 25000.0 shares on Jun 11 ’25.
